NCT01963793View on ClinicalTrials.gov

Topical Aprepitant in Prurigo Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Pruritus

Interventions

DRUG

Aprepitant

Aprepitant gel (10 mg/g)

DRUG

Placebo

gel without active component

Trial Locations (1)

D-10117

Allergie-Zentrum-Charité, Charité - Universitätsmedizin Berlin, Berlin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LEO Pharma

INDUSTRY

NCT01963793 - Topical Aprepitant in Prurigo Patients | Biotech Hunter | Biotech Hunter